In spite of a concern regarding the discordance between animal and human in drug efficacy and toxicities47, treatment of canine cancer may benefit from the development of novel human cancer drugs that target shared oncogenic mutations (e.g., alpelisib for metastatic breast cancer with PIK3CA mutations48). This evidence concerns the gene PIK3CA and cancer.